Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Gabriel Civallero"'
Autor:
Gabriel Civallero, Francyne Kubaski, Danilo Pereira, Gabriel Rübensam, Zackary M. Herbst, Camilo Silva, Franciele B. Trapp, Edina Poletto, Larissa Faqueti, Gabrielle Iop, Juliano Soares, Vanessa van der Linden, Helio van der Linden, Charles M. Lourenço, Roberto Giugliani
Publikováno v:
Molecular Genetics and Metabolism Reports, Vol 34, Iss , Pp 100945- (2023)
Externí odkaz:
https://doaj.org/article/406b9bb4aec246ce8befa5dec9f86fa8
Autor:
Gabriel Civallero, Francyne Kubaski, Danilo Pereira, Gabriel Rübensam, Zackary M. Herbst, Camilo Silva, Franciele B. Trapp, Edina Poletto, Larissa Faqueti, Gabrielle Iop, Juliano Soares, Vanessa van der Linden, Helio van der Linden, Charles M. Lourenço, Roberto Giugliani
Publikováno v:
Molecular Genetics and Metabolism Reports, Vol 32, Iss , Pp 100888- (2022)
Aromatic l-amino acid decarboxylase (AADC, EC 4.1.1.28) deficiency is a rare genetic disorder characterized by developmental delay, oculogyric crises, autonomic dysfunction and other problems, caused by biallelic mutations in the DDC gene leading to
Externí odkaz:
https://doaj.org/article/a1d507af4e944e219f4ad7abb6ceaf12
Autor:
Fernanda Medeiros Sebastião, Maira Graeff Burin, Gabriel Civallero, Kristiane Michelin Tirelli, Angela Sitta, Daniella de Moura Coelho, Carmen Regla Vargas, Moacir Wajner, Roberto Giugliani, Fernanda Hendges de Bitencourt, Ida Vanessa Doederlein Schwartz
Publikováno v:
Journal of Inborn Errors of Metabolism and Screening, Vol 8 (2020)
Abstract Phenylketonuria (PKU) is caused by deficient activity of phenylalanine hydroxylase (PAH), responsible for the conversion of phenylalanine (Phe) to tyrosine (Tyr). Monitoring of patients with PKU requires the measurement of Phe in plasma usin
Externí odkaz:
https://doaj.org/article/eb149316c07c43b897c7c1aa5235fb39
Publikováno v:
Journal of Inborn Errors of Metabolism and Screening, Vol 6 (2018)
Inborn errors of metabolism (IEM) are a large and heterogeneous group of genetic diseases. In most of these conditions, the presence of variants in specific genes leads to enzyme deficiencies that affect a particular metabolic step. The number of lab
Externí odkaz:
https://doaj.org/article/3765bf38f5d04ace8039318f86b33af6
Autor:
Graziela Schmitt Ribas PhD, Jurema Fátima De Mari, Gabriel Civallero PhD, Heryk Motta de Souza, Maira Graeff Burin PhD, Carmen Regla Vargas PhD, Roberto Giugliani PhD
Publikováno v:
Journal of Inborn Errors of Metabolism and Screening, Vol 5 (2017)
Background: Interest in screening methods for lysosomal storage diseases (LSDs) has increased in recent years, since early diagnosis and treatment are essential to prevent or attenuate the onset of symptoms and the complications of these diseases. In
Externí odkaz:
https://doaj.org/article/ce833493563641e6a5b3bc28e45ba1f4
Autor:
Fernanda Bender, Maira G. Burin, Kristiane M. Tirelli, Fernanda Medeiros, Fernanda Hendges de Bitencourt, Gabriel Civallero, Francyne Kubaski, Heydy Bravo, Antoine Daher, Vanessa Carnier, José F. S. Franco, Roberto Giugliani
Publikováno v:
Genetics and Molecular Biology
Abstract Lysosomal storage disorders (LSDs) are a group of genetic disorders characterized by deficiency of specific lysosomal enzymes. In general, patients are clinically normal at birth, and progressively develop severe signs and symptoms. Diagnosi
Externí odkaz:
https://doaj.org/article/5ce6ed24daa74d5bb3c061e2e843345f
Autor:
Gabriel Civallero, Francyne Kubaski, Danilo Pereira, Gabriel Rübensam, Zackary M. Herbst, Camilo Silva, Franciele B. Trapp, Edina Poletto, Larissa Faqueti, Gabrielle Iop, Juliano Soares, Vanessa van der Linden, Helio van der Linden, Charles M. Lourenço, Roberto Giugliani
Publikováno v:
Mol Genet Metab Rep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32ef75b8ef82bbd69d12f618cfc1ae29
https://europepmc.org/articles/PMC9979259/
https://europepmc.org/articles/PMC9979259/
Autor:
Fernanda Hendges de Bitencourt, Fernanda da Silva Medeiros, Fernanda Bender, Maira Graeff Burin, Antoine Daher, José Francisco Da Silva Franco, Francyne Kubaski, Kristiane Michelin Tirelli, Heydy Bravo, Gabriel Civallero, Roberto Giugliani, Vanessa Carnier
Publikováno v:
Genetics and Molecular Biology
Genetics and Molecular Biology v.43 n.2 2020
Sociedade Brasileira de Genética (SBG)
instacron:SBG
Genetics and Molecular Biology v.43 n.2 2020
Sociedade Brasileira de Genética (SBG)
instacron:SBG
Lysosomal storage disorders (LSDs) are a group of genetic disorders characterized by deficiency of specific lysosomal enzymes. In general, patients are clinically normal at birth, and progressively develop severe signs and symptoms. Diagnosis is usua
Publikováno v:
Repositório Institucional da UFRGS
Universidade Federal do Rio Grande do Sul (UFRGS)
instacron:UFRGS
Journal of Inborn Errors of Metabolism and Screening v.6 2018
Journal of Inborn Errors of Metabolism and Screening
Instituto Genética para Todos (IGPT)
instacron:IGPT
Journal of Inborn Errors of Metabolism and Screening, Volume: 6, Article number: e180010, Published: 28 FEB 2019
Universidade Federal do Rio Grande do Sul (UFRGS)
instacron:UFRGS
Journal of Inborn Errors of Metabolism and Screening v.6 2018
Journal of Inborn Errors of Metabolism and Screening
Instituto Genética para Todos (IGPT)
instacron:IGPT
Journal of Inborn Errors of Metabolism and Screening, Volume: 6, Article number: e180010, Published: 28 FEB 2019
Inborn errors of metabolism (IEM) are a large and heterogeneous group of genetic diseases. In most of these conditions, the presence of variants in specific genes leads to enzyme deficiencies that affect a particular metabolic step. The number of lab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f093c4b9176c8ca745a68bbb167975a
Autor:
Carolina Fischinger Moura de Souza, Guilherme Baldo, Gabriel Civallero, Ana Carolina Brusius-Facchin, Maira Graeff Burin, Filippo Vairo, Roberto Giugliani, Sandra Leistner-Segal
Publikováno v:
Expert Opinion on Orphan Drugs. 3:141-150
Introduction: Hunter syndrome (Mucopolysaccharidosis II, MPS II) is a lysosomal storage disease inherited as an X-linked trait. The disease is progressive, affects multiple systems and is clinically heterogeneous. Patients with the so-called ‘atten